Aspira Women’s Health Inc. Net Income (Loss) Available to Common Stockholders, Diluted
Aspira Women’s Health Inc. (AWHL) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$2.37 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-05-15
- Aspira Women’s Health Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2026-03-31 was -$2.37M.
- Aspira Women’s Health Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2025-03-31 was -$1.85M.
- Aspira Women’s Health Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2023-03-31 was -$6.07M.
- Aspira Women’s Health Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2022-03-31 was -$9.27M.
- Aspira Women’s Health Inc. net income (loss) available to common stockholders, diluted for fiscal 2022 was -$29.89M.
- Aspira Women’s Health Inc. net income (loss) available to common stockholders, diluted for fiscal 2021 was -$31.66M.
- Aspira Women’s Health Inc. net income (loss) available to common stockholders, diluted for fiscal 2020 was -$17.91M.
- Aspira Women’s Health Inc. net income (loss) available to common stockholders, diluted for fiscal 2019 was -$15.24M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month as first filed |
|---|---|---|---|
| 2026-03-31 | -$2.37M 10-Q · filed 2026-05-15 | ||
| 2025-03-31 | -$1.85M 10-Q · filed 2026-05-15 | ||
| 2023-03-31 | -$6.07M 10-Q · filed 2023-05-15 | ||
| 2022-12-31 | -$29.89M 10-K/A · filed 2023-10-26 | -$27.17M 10-K · filed 2023-03-30 | |
| 2022-03-31 | -$9.27M 10-Q · filed 2023-05-15 | ||
| 2021-12-31 | -$31.66M 10-K/A · filed 2023-10-26 | ||
| 2020-12-31 | -$17.91M 10-K · filed 2022-03-31 | ||
| 2019-12-31 | -$15.24M 10-K · filed 2021-03-31 | ||
| 2018-12-31 | -$11.37M 10-K · filed 2020-04-07 | ||
| 2017-12-31 | -$11.44M 10-K · filed 2019-03-28 | ||
| 2016-12-31 | -$14.97M 10-K · filed 2018-03-13 | ||
| 2015-12-31 | -$19.11M 10-K · filed 2017-03-31 | ||
| 2014-12-31 | -$19.21M 10-K · filed 2016-03-30 | ||
| 2013-12-31 | -$8.82M 10-K · filed 2015-03-31 | ||
| 2012-12-31 | -$7.15M 10-K · filed 2014-03-31 | ||
| 2011-12-31 | -$17.79M 10-K · filed 2013-03-01 |